Gateway 2011: Corden Pharma
Corden Pharma
Otto-Hahn-Strasse
68723 Plankstadt, Germany
Phone: +49 6202 99-2299
Fax: +49 6202 99-2000
E-mail: sales@cordenpharma.com
Website: www.cordenpharma.com
General Company Company Description:
Corden Pharma is a specialized contract manufacturer utilizing sophisticated technologies developed through years of proven experience that are ideal for the production of oral and sterile highly potent or antibiotic pharmaceutical products and their active ingredients.
We offer customised service packages which span the entire pharmaceutical product continuum from development and manufacturing of Active Pharmaceuticals Ingredients, formulation development, assistance with approval procedures, and commercial production of Drug Products, all the way to complete pharmaceutical logistics.
Our plants, located across Europe and in the US, are audited by all relevant approval authorities, making Corden Pharma a premier partner for pharmaceutical companies worldwide.
Visit Corden Pharma at CPhI booth 31B04 and/or AAPS booth 1524 to discover the services, technologies and products which distinguish Corden Pharma as a Full-Service Development and Contract Manufacturer:
- Custom API Manufacturing
- Generic API Manufacturing
- Drug Product Development and Manufacturing
- Generic Dossier Development
- Formulation Capabilities
- Packaging
- Clinical Supply Services
- Specialized Technologies, including High Potent APIs and Peptides
- Readily Available Excipients, Building Blocks and Generic Bulk APIs
Contact:
sales@cordenpharma.com to arrange meetings for CPhI
contactUS@cordenpharma.comto arrange meetings for AAPS
Corden Pharma Switzerland Custom Manufacturing Brochure
Corden Pharma Switzerland Lipids Brochure
Corden Pharma Switzerland Lipids Price List
Corden Pharma Switzerland Pseudoproline Dipeptides Brochure
Corden Pharma Switzerland Pseudoproline Dipeptides Price List
Corden Pharma Switzerland Oligonucleotide-Based Therapeutic Delivery
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
